TFS Capital’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

TFS Capital’s Portfolio BDSI Stock Details BDSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-25,517	Closed	-$45K	–	1010
2016 Q4	$45K	Sell	25,517 -21,665	-46%	-$44.2K	0.01%	695
2016 Q3	$127K	Buy	47,182 +20,738	+78%	+$52.7K	0.03%	618
2016 Q2	$62K	Sell	26,444 -27,268	-51%	-$75.2K	0.01%	903
2016 Q1	$173K	Buy	+53,712	New	+$198K	0.02%	803
2015 Q4	–	Sell	-15,519	Closed	-$86K	–	1107
2015 Q3	$86K	Sell	15,519 -11,758	-43%	-$86.8K	0.01%	814
2015 Q2	$217K	Buy	+27,277	New	+$234K	0.02%	739
2014 Q3	–	Sell	-18,086	Closed	-$218K	–	1446
2014 Q2	$218K	Buy	18,086 +6,801	+60%	+$64.5K	0.02%	921
2014 Q1	$95K	Buy	+11,285	New	+$91.1K	0.01%	1286

Other funds holding BDSI

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GPGA

Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

TFS Capital's BDSI Position: Q1 2017 in Review

TFS Capital sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2017, closing a stake of 25,517 shares — an estimated $45K sold.

TFS Capital first reported a position in BDSI in Q1 2014 and held it in 8 quarters. The position peaked at $218K in Q2 2014. 63 funds tracked by Wall St. Rank hold BDSI as of Q1 2017.

TFS Capital reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2017 after selling out during the quarter.
TFS Capital sold 25,517 BioDelivery Sciences International, Inc. shares in Q1 2017, an estimated $45K.
TFS Capital first reported a position in BioDelivery Sciences International, Inc. in Q1 2014 and held it in 8 quarters.
TFS Capital's BioDelivery Sciences International, Inc. position peaked at $218K in Q2 2014.
63 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2017.

Based on TFS Capital's 13F filing for Q1 2017, filed 5 May 2017.